PeptisynthaServicesNews
This Site All Sites
 
News
>
 
  News
  December 01, 2009   Key industry professionals to join peptide and oligonucleotide teams at Solvay’s Peptisyntha and Girindus businesses
PEPTISYNTHA, a service provider to the pharmaceutical industry and a leading manufacturer of therapeutic peptides, is pleased to announce the appointment of Dr. Mimoun Ayoub. Dr. Ayoub will assume the position of VP Strategic Development, as of January 1st, 2010.
[EN]
 
  April 01, 2009   US FDA successfully inspects Peptisyntha’s Peptide APIs manufacturing plant in Belgium
Peptisyntha, one of the world's leading therapeutic peptides manufacturing companies, is pleased to announce the successful outcome of the recent inspection of its manufacturing facility in Brussels, Belgium by the United States Food and Drug Administration (FDA).
[EN]
 
  April 07, 2008   Peptisyntha Inc. expands its facility in Torrance, California
Peptisyntha Inc. has started the next expansion of its cGMP-compliant manufacturing facilities in Torrance, California.
[EN]
 
  February 28, 2007   Peptisyntha SA expands its production capacity in Brussels, Belgium
Peptisyntha SA has launched the expansion of its pilot-scale capacity for the production of cGMP bulk peptides based on solution phase technology at its production plant in Brussels, Belgium.
[EN]
 
  February 16, 2005   Frost and Sullivan Award underlines Peptisyntha's unwavering customer focus
In bestowing the 2005 Customer Value Award for the European therapeutic peptides market to Peptisyntha, Frost & Sullivan lauds it as a company that has provided customers with high quality yet extremely competitively priced peptide products and services.
[EN]
 
  September 15, 2004   Peptisyntha, Inc. Expands Existing Facility
Peptisyntha, Inc. has begun work to expand laboratory space at its cGMP-compliant manufacturing facilities located in Torrance, California. Construction of the new space is in progress and will be completed by March 2005.
[EN]
 
  September 06, 2001   Solvay expands its successful peptide activities through the incorporation of Peptisyntha, Inc. in the US
Technological synergies and geographic expansion.
[EN]-[FR]-[NL]
 
 
accueil
© Solvay S.A • Important information : Privacy Policy  -  Disclaimer • If you have any comments, please contact the webmaster
Date of last update: 10/2/2010